BioTech
A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down
A clutch of headlines last week suggested the U.S. Senate had achieved a breakthrough in the battle to prevent pharmaceutical companies from abusing the patent
Ed Silverman and Rachel Cohrs Zhang
July 17, 2024